Epithelial ovarian cancer (EOC) is a lethal gynecologic disease that imposes significant burden on health care and patient quality of life. Highâ€grade serous carcinoma of the ovary (HGSC) is the most prevalent histologic type of EOC. A vast majority of HGSC cases are identify at late stages of the disease, limiting the opportunity for clinical intervention and resulting in a 10â€year survival rate of <20%. Recent innovations in highâ€throughput molecular analysis of patientâ€derived specimens may address these clinical challenges by providing an enhanced understanding of the molecular aetiology of ovarian cancer, in addition to offering several opportunities for rational biomarker and targeted therapy discovery. In this review, we highlight the most significant contributions of omics approaches and how the advent of immunomics can aid in personalized combination chemoâ€immunotherapy in ovarian cancer treatment. We further provide insights into immunogenomic correlates of preâ€treatment tumour immune microenvironment and some of the potential interpretations of immunomic data that require further validation, based on stromal and immune contributions to biomarker signatures. We believe a comprehensive integrative approach via metaâ€analysis of large ovarian cancer molecular profiling data sets is urgently needed to define robust prognostic and predictive classifiers of disease progression and treatment response. These investigations will inform rationalized biomarkerâ€driven combination chemoâ€immunotherapy trials for improving response and survival of ovarian cancer patients.
Review Article: Journal of Cancer Clinical Trials
Review Article: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Research Article: Journal of Cancer Clinical Trials
Research Article: Journal of Cancer Clinical Trials
Research Article: Journal of Cancer Clinical Trials
Research Article: Journal of Cancer Clinical Trials
Case Report: Journal of Cancer Clinical Trials
Case Report: Journal of Cancer Clinical Trials
Posters & Accepted Abstracts: Journal of Clinical Case Reports
Posters & Accepted Abstracts: Journal of Clinical Case Reports
Accepted Abstracts: Journal of AIDS & Clinical Research
Accepted Abstracts: Journal of AIDS & Clinical Research
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Journal of Cancer Clinical Trials received 95 citations as per Google Scholar report